TapewireFind a company

person · Reporting owner

Hammons Terry

Disclosed activity across 2 companies

Tapewire entity
129513
SEC CIK
0001801393

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Simpson Manufacturing Co., Inc.SSD · Entity 3689SVP, General CounselFebruary 16, 2021February 19, 2021
Sotera Health CoSHC · Entity 3869SVP, GC and SecretaryMarch 02, 2022March 04, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Simpson Manufacturing Co., Inc.

Report date February 16, 2021 · Filed February 19, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect1,558 Reported balance After 2021-02-16 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2021-02-16 · Tax withholding · Disposed 34 · Balance 1,558

F1: Represents shares of common stock withheld by the Company to satisfy the tax withholding obligation for the reporting person's restricted stock units that vested on February 16, 2021.

F2: Includes 1,480 restricted stock units that have not yet vested.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares of common stock withheld by the Company to satisfy the tax withholding obligation for the reporting person's restricted stock units that vested on February 16, 2021.

F2: Includes 1,480 restricted stock units that have not yet vested.

Sotera Health Co

Report date March 02, 2022 · Filed March 04, 2022

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock, $0.01 par value per share ("Common Stock")SEC Table I · non-derivativeDirect31,257 Reported balance After 2022-03-02 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2022-03-02 · Grant · Acquired 22,466 · Balance 31,257

F1: These securities consist of Restricted Stock Units ("RSUs") that were granted on March 2, 2022, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of common stock, subject to vesting conditions. The RSUs vest in three equal installments on each of the first three anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date.

F2: These securities consists of 31,257 RSUs.

Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $20.03 · Expires 2032-03-02Direct57,471 Reported balance After 2022-03-02 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2022-03-02 · Grant · Acquired 57,471 · Balance 57,471

F3: These options were granted on March 2, 2022, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in three equal installments on each of the first three anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date.

Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $22.75 · Expires 2031-11-11Direct37,676 Reported balance Holding disclosure · report date 2022-03-02 · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · Balance 37,676

F4: No transaction is being reported on this line. Reported on a previously filed Form 4.

F5: These options were granted on November 11, 2021, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in four equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date.

Filing footnotes · ownership attribution and instrument terms

F1: These securities consist of Restricted Stock Units ("RSUs") that were granted on March 2, 2022, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of common stock, subject to vesting conditions. The RSUs vest in three equal installments on each of the first three anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date.

F2: These securities consists of 31,257 RSUs.

F3: These options were granted on March 2, 2022, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in three equal installments on each of the first three anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date.

F4: No transaction is being reported on this line. Reported on a previously filed Form 4.

F5: These options were granted on November 11, 2021, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in four equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
March 02, 2022 Filed Mar 4, 2022 16:14 UTC Sotera Health Co SHC · Entity 3869 GrantStock Options · Derivative 57,471 $0.00 Strike: $20.03 $0.00
Disclosure

SEC source: 0001822479-22-000022 · wf-form4_164642843887831.xml · derivative · entry 2

Hammons Terry · CIK 0001801393 · SVP, GC and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,471

Underlying: Common Stock · 57,471 shares

Expires 2032-03-02

F3 · derivative.exercise_date: These options were granted on March 2, 2022, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in three equal installments on each of the first three anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date.

F3 · balance_after: These options were granted on March 2, 2022, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in three equal installments on each of the first three anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date.

Read SEC document
March 02, 2022 Filed Mar 4, 2022 16:14 UTC Sotera Health Co SHC · Entity 3869 GrantCommon Stock, $0.01 par value per share ("Common Stock") 22,466 $0.00 $0.00
Disclosure

SEC source: 0001822479-22-000022 · wf-form4_164642843887831.xml · nonDerivative · entry 1

Hammons Terry · CIK 0001801393 · SVP, GC and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,257

F1 · shares: These securities consist of Restricted Stock Units ("RSUs") that were granted on March 2, 2022, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of common stock, subject to vesting conditions. The RSUs vest in three equal installments on each of the first three anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date.

F2 · balance_after: These securities consists of 31,257 RSUs.

Read SEC document
November 11, 2021 Filed Nov 12, 2021 16:58 UTC Sotera Health Co SHC · Entity 3869 GrantStock Options · Derivative 37,676 $0.00 Strike: $22.75 $0.00
Disclosure

SEC source: 0001822479-21-000071 · wf-form4_163675429871636.xml · derivative · entry 2

Hammons Terry · CIK 0001801393 · SVP, GC and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,676

Underlying: Common Stock · 37,676 shares

Expires 2031-11-11

F2 · derivative.exercise_date: These options were granted on November 11, 2021, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in four equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date.

Read SEC document
November 11, 2021 Filed Nov 12, 2021 16:58 UTC Sotera Health Co SHC · Entity 3869 GrantCommon Stock, $0.01 par value per share ("Common Stock") 8,791 $0.00 $0.00
Disclosure

SEC source: 0001822479-21-000071 · wf-form4_163675429871636.xml · nonDerivative · entry 1

Hammons Terry · CIK 0001801393 · SVP, GC and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,791

F1 · shares: These securities consist of Restricted Stock Units ("RSUs") that were granted on November 11, 2021, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of common stock, subject to vesting conditions. The RSUs vest in four equal installments on each of the first four anniversaries of the date of grant.

Read SEC document
February 16, 2021 Filed Feb 19, 2021 00:33 UTC Simpson Manufacturing Co., Inc. SSD · Entity 3689 Tax withholdingCommon Stock 34 $95.53 $3,248.02
Disclosure

SEC source: 0000920371-21-000035 · wf-form4_161369477281005.xml · nonDerivative · entry 1

Hammons Terry · CIK 0001801393 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,558

F1 · shares: Represents shares of common stock withheld by the Company to satisfy the tax withholding obligation for the reporting person's restricted stock units that vested on February 16, 2021.

F2 · balance_after: Includes 1,480 restricted stock units that have not yet vested.

Read SEC document
January 22, 2021 Filed Jan 26, 2021 22:13 UTC Simpson Manufacturing Co., Inc. SSD · Entity 3689 GrantCommon Stock 1,030 $0.00 $0.00
Disclosure

SEC source: 0000920371-21-000017 · wf-form4_161169919765487.xml · nonDerivative · entry 1

Hammons Terry · CIK 0001801393 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,592

F1 · shares: Represents Restricted Stock Units (RSUs). Each RSU represents a right to receive, subject to the terms and conditions of the 2011 Equity Incentive Plan and a RSU Award Agreement, one share of the Company's common stock subject to vesting in three annual installments, beginning in February 2022.

F2 · balance_after: Includes 1,592 Restricted Stock Units that have not yet vested.

Read SEC document
February 13, 2020 Filed Feb 19, 2020 01:25 UTC Simpson Manufacturing Co., Inc. SSD · Entity 3689 GrantCommon Stock 562 $0.00 $0.00
Disclosure

SEC source: 0000920371-20-000038 · wf-form4_158207550619514.xml · nonDerivative · entry 1

Hammons Terry · CIK 0001801393 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 562

F1 · shares: Represents Restricted Stock Units (RSUs). Each RSU represents a right to receive, subject to the terms and conditions of the 2011 Equity Incentive Plan and a RSU Award Agreement, one share of the Company's common stock subject to vesting in three annual installments, as follows: 20% in the first year, 40% in the second year, and 40% in the third year.

F2 · balance_after: Includes 562 Restricted Stock Units that have not yet vested.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.